Cargando…
Insufficient serum L-ficolin is associated with disease presence and extent of pulmonary Mycobacterium avium complex disease
BACKGROUND: The incidence of infectious disease caused by nontuberculous mycobacteria is increasing worldwide. Pulmonary Mycobacterium avium complex (MAC) disease is difficult to treat with chemotherapy, and its mechanism of infection, infection route, disease onset, and severity remain unknown. Fic...
Autores principales: | Kobayashi, Tomofumi, Kuronuma, Koji, Saito, Atsushi, Ikeda, Kimiyuki, Ariki, Shigeru, Saitou, Atsushi, Otsuka, Mitsuo, Chiba, Hirofumi, Takahashi, Satoshi, Takahashi, Motoko, Takahashi, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805425/ https://www.ncbi.nlm.nih.gov/pubmed/31638993 http://dx.doi.org/10.1186/s12931-019-1185-9 |
Ejemplares similares
-
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis
por: Takahashi, Youhei, et al.
Publicado: (2018) -
Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis
por: Nishikiori, Hirotaka, et al.
Publicado: (2014) -
N‐glycosylation regulates MET processing and signaling
por: Saitou, Atsushi, et al.
Publicado: (2022) -
Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage
por: Shioya, Makoto, et al.
Publicado: (2018) -
Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
por: Yoshikawa, Takumi, et al.
Publicado: (2020)